Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Human immunodeficiency virus type 1 and hepatitis B virus transcription in peripheral blood lymphocytes from co-infected subjects.

Literature DB >> 1524492

Human immunodeficiency virus type 1 and hepatitis B virus transcription in peripheral blood lymphocytes from co-infected subjects.

M Clementi¹, A Manzin, P Bagnarelli, S Menzo, P E Varaldo, G Carloni.

Abstract

The molecular characteristics of peripheral blood lymphocyte (PBL) infection by hepatitis B virus (HBV) were studied in human immunodeficiency virus type 1 (HIV-1) infected subjects using highly sensitive polymerase chain reaction (PCR) based techniques. DNA and RNA samples were purified from PBLs of HIV-1 infected individuals, regardless of their HBV serological status and assayed using PCR and reverse-transcription (RT) PCR, respectively. The data shown here are an extension of previous reports documenting HBV and HIV-1 co-infection of PBLs and indicate that transcriptionally active HBV infection of PBLs is detectable in a significant proportion of asymptomatic HIV-1 infected patients.

Entities: Disease Species

Mesh：

Substances：
DNA, Viral
RNA, Viral

Year: 1992 PMID： 1524492 DOI： 10.1007/bf01309679

Source DB: PubMed Journal: Arch Virol ISSN： 0304-8608 Impact factor: 2.574

28 in total

Review 1. The hepatitis B virus and the peripheral blood mononuclear cells: a brief review.

Authors: J P Lamelin; C Trépo
Journal: J Hepatol Date: 1990-01 Impact factor: 25.083

2. The Epstein-Barr virus BRLF1 immediate-early gene product transactivates the human immunodeficiency virus type 1 long terminal repeat by a mechanism which is enhancer independent.

Authors: E B Quinlivan; E Holley-Guthrie; E C Mar; M S Smith; S Kenney
Journal: J Virol Date: 1990-04 Impact factor: 5.103

3. Detection of mononuclear cells expressing hepatitis B virus in peripheral blood from HBsAg positive and negative patients by in situ hybridisation.

Authors: M Hadchouel; C Pasquinelli; J G Fournier; R N Hugon; J Scotto; O Bernard; C Brechot
Journal: J Med Virol Date: 1988-01 Impact factor: 2.327

4. Detection of human immunodeficiency virus type 1 genomic RNA in plasma samples by reverse-transcription polymerase chain reaction.

Authors: P Bagnarelli; S Menzo; A Manzin; M Giacca; P E Varaldo; M Clementi
Journal: J Med Virol Date: 1991-06 Impact factor: 2.327

5. trans-activation of viral enhancers including long terminal repeat of the human immunodeficiency virus by the hepatitis B virus X protein.

Authors: A Siddiqui; R Gaynor; A Srinivasan; J Mapoles; R W Farr
Journal: Virology Date: 1989-04 Impact factor: 3.616

6. The human papillomavirus type 16 E7 gene encodes transactivation and transformation functions similar to those of adenovirus E1A.

Authors: W C Phelps; C L Yee; K Münger; P M Howley
Journal: Cell Date: 1988-05-20 Impact factor: 41.582

7. An Epstein-Barr virus immediate-early gene product trans-activates gene expression from the human immunodeficiency virus long terminal repeat.

Authors: S Kenney; J Kamine; D Markovitz; R Fenrick; J Pagano
Journal: Proc Natl Acad Sci U S A Date: 1988-03 Impact factor: 11.205

8. Production of hepatitis B virus-infected human B-cell hybridomas: transmission of the viral genome to normal lymphocytes in cocultures.

Authors: G Colucci; P Lyons; Y Beazer; S D Waksal
Journal: Virology Date: 1988-05 Impact factor: 3.616

9. Multiple transcriptional regulatory domains in the human immunodeficiency virus type 1 long terminal repeat are involved in basal and E1A/E1B-induced promoter activity.

Authors: S Kliewer; J Garcia; L Pearson; E Soultanakis; A Dasgupta; R Gaynor
Journal: J Virol Date: 1989-11 Impact factor: 5.103

Human immunodeficiency virus type 1 and hepatitis B virus transcription in peripheral blood lymphocytes from co-infected subjects.

Review 1. The hepatitis B virus and the peripheral blood mononuclear cells: a brief review.

2. The Epstein-Barr virus BRLF1 immediate-early gene product transactivates the human immunodeficiency virus type 1 long terminal repeat by a mechanism which is enhancer independent.

3. Detection of mononuclear cells expressing hepatitis B virus in peripheral blood from HBsAg positive and negative patients by in situ hybridisation.

4. Detection of human immunodeficiency virus type 1 genomic RNA in plasma samples by reverse-transcription polymerase chain reaction.

5. trans-activation of viral enhancers including long terminal repeat of the human immunodeficiency virus by the hepatitis B virus X protein.

6. The human papillomavirus type 16 E7 gene encodes transactivation and transformation functions similar to those of adenovirus E1A.

7. An Epstein-Barr virus immediate-early gene product trans-activates gene expression from the human immunodeficiency virus long terminal repeat.

8. Production of hepatitis B virus-infected human B-cell hybridomas: transmission of the viral genome to normal lymphocytes in cocultures.

9. Multiple transcriptional regulatory domains in the human immunodeficiency virus type 1 long terminal repeat are involved in basal and E1A/E1B-induced promoter activity.

10. Systemic distribution of woodchuck hepatitis virus in the tissues of experimentally infected woodchucks.

Review 1. Clinical use of quantitative molecular methods in studying human immunodeficiency virus type 1 infection.

2. Dynamics and modulation of human immunodeficiency virus type 1 transcripts in vitro and in vivo.

Review 3. Quantitative molecular methods in virology.

4. Molecular profile of human immunodeficiency virus type 1 infection in symptomless patients and in patients with AIDS.